# Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression

> **NCT01309581** · NA · TERMINATED · sponsor: **James Murrough** · enrollment: 3 (actual)

## Conditions studied

- Major Depression
- Bipolar Depression

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Methohexital

## Key facts

- **NCT ID:** NCT01309581
- **Lead sponsor:** James Murrough
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** limited enrollment
- **Last updated:** 2013-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01309581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01309581, "Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01309581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*